Is FONAR Corp. overvalued or undervalued?

As of 21 July 2025, the valuation grade for FONAR Corp. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be fairly valued at this time. Key valuation ratios include a P/E ratio of 8, a Price to Book Value of 0.53, and an EV to EBITDA of 2.31.
In comparison to its peers, FONAR Corp. has a P/E ratio of 8.9956, which is relatively favorable given that Longboard Pharmaceuticals, Inc. has a significantly negative P/E of -27.0419, while Performant Financial Corp. shows a risky valuation with a P/E of -602.7473. Despite its fair valuation, FONAR Corp. has underperformed against the S&P 500 over the past year, with a return of -10.86% compared to the index's 17.14%, suggesting that the market may be pricing in concerns regarding its future growth potential.